Geerard L. Beets - Concepedia

Author

Geerard L. Beets

Also Known As

B K Bednarski, B. K. Bednarski, Beets-Tan, Regina, Beets-Tan, Regina G. H., Beets-Tan, Regina G.H., Dutch Stage IV Rectal Cancer Group, Eddy Adang, G BEETS, G Beets, G L Beets

724

Publications

45.6K

Citations

103

H-Index

152

Concepts

All Affiliations

Maastricht University Maastricht University Medical Centre The Netherlands Cancer Institute Oncode Institute Radboud University Nijmegen

About

Geerard L. Beets is an author at Maastricht University specializing in medicine, oncology, and radiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	49	115	15.5K
2	Health Sciences	35	58	6.2K
3	Engineering	20	30	2.3K
4	Anatomy	2	2	63
5	Public Health	1	1	17

Geerard L. Beets

247

Publications

27.4K

Citations

H-Index

Page 1

	Year	Citations
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data Monique Maas, Patty J. Nelemans, Vincenzo Valentini, The Lancet Oncology Surgical OncologyRadiation TherapyIndividual Patient DataCancer RecurrenceMedicine	2010	1.9K
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten, The Lancet Oncology Surgical OncologyRadiation TherapyGastrointestinal OncologyMedicineColorectal Cancer	2020	1.5K
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making Hans‐Joachim Schmoll, Eric Van Cutsem, Alexander Stein, Annals of Oncology Esmo Consensus GuidelinesPersonalized ApproachGastrointestinal OncologyColorectal SurgeryMedicine	2012	1.5K
Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers Myriam Chalabi, Lorenzo F. Fanchi, Krijn K. Dijkstra, Nature Medicine Neoadjuvant ImmunotherapyTumor ImmunologyCancer ImmunosurveillanceGastrointestinal OncologyMedicine	2020	1.3K
Wait-and-See Policy for Clinical Complete Responders After Chemoradiation for Rectal Cancer Monique Maas, Geerard L. Beets, Doenja M. J. Lambregts, Journal of Clinical Oncology	2011	1.1K
Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study Maxime J.M. van der Valk, Denise E. Hilling, Esther Bastiaannet, The Lancet International WatchSurgical OncologyGastrointestinal OncologyMedicineClinical Trials	2018	1K
Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer Atsushi Ogura, Tsuyoshi Konishi, Chris Cunningham, Journal of Clinical Oncology	2018	483
Functional Compromise Reflected by Sarcopenia, Frailty, and Nutritional Depletion Predicts Adverse Postoperative Outcome After Colorectal Cancer Surgery Kostan W. Reisinger, Jeroen L.A. van Vugt, Juul J.W. Tegels, Annals of Surgery	2014	482
High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size? Joo Hee Kim, Geerard L. Beets, Myeong‐Jin Kim, European Journal of Radiology Nodal StagingEngineeringOncologic ImagingMedical ImagingBiomedical Imaging	2004	416
Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer Milou H. Martens, Monique Maas, Luc A. Heijnen, JNCI Journal of the National Cancer Institute	2016	414

Page 1